Mymeleon AG is a Swiss-based holding company founded in 2015 with the goal of developing new concepts in health prevention to keep people
happy and healthy.
The founders and management team have extensive experience in healthcare, technology and lifestyle, plus a history of successful exit strategies (M&A and IPO).
Mymeleon was not originally created to be a company.
It was built to accomplish a social mission:
anti-inflammage people to keep avoidable disease like cancer, stroke, and Alzheimer’s away.
To promote a healthy balanced lifestyle by reducing low-grade chronic inflammation, using the Anti-Inflammaging API
Headquarters & Holding
EU Representative Office
650 Page Mill Road
94304-1050 Palo Alto
United States of America
AU Representative Office
Dr. Kellie Pritchard-Peschek
1 Mark Street